Trial Profile

Registration study of XIAFLEX in patients with Dupuytren's nodules

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 22 May 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Collagenase clostridium histolyticum (Primary)
Indications Dupuytren's contracture
Focus Registrational; Therapeutic Use

Most Recent Events

23 Apr 2024 According to Endo International Media Release, Endo, Inc. a newly formed entity has acquired Endo International plc.
20 May 2016 New trial record
10 May 2016 According to BioSpecifics Technologies Corp media release, this trial is expected to initiate in the fourth quarter of 2016.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com